These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17582289)

  • 21. Usefulness of 64-slice cardiac computed tomographic angiography for diagnosing acute coronary syndromes and predicting clinical outcome in emergency department patients with chest pain of uncertain origin.
    Rubinshtein R; Halon DA; Gaspar T; Jaffe R; Karkabi B; Flugelman MY; Kogan A; Shapira R; Peled N; Lewis BS
    Circulation; 2007 Apr; 115(13):1762-8. PubMed ID: 17372178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of myeloperoxidase in the differential diagnosis of acute coronary syndrome.
    Calmarza P; Lapresta C; Martínez M; Lahoz R; Povar J
    Arch Cardiol Mex; 2018 Dec; 88(5):391-396. PubMed ID: 29233491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of "admission index of insulin resistance (AIRI)" as an early stage risk predictor in nondiabetic acute coronary syndromes].
    Içli A; Gök H; Altunkeser BB; Ozdemir K; Gürbilek M; Gederet YT; Sökmen G
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):194-201. PubMed ID: 12223324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of uric acid in patients with acute coronary syndromes.
    Ndrepepa G; Braun S; Haase HU; Schulz S; Ranftl S; Hadamitzky M; Mehilli J; Schömig A; Kastrati A
    Am J Cardiol; 2012 May; 109(9):1260-5. PubMed ID: 22325088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between plasma myeloperoxidase levels and angiographic severity of coronary artery disease in patients with acute coronary syndrome.
    de Azevedo Lucio E; Gonçalves SC; Ribeiro JP; Nunes GL; de Oliveira JR; Araujo GN; Wainstein MV
    Inflamm Res; 2011 Feb; 60(2):137-42. PubMed ID: 20848159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing local and systemic levels of plasma myeloperoxidase in ST-segment elevation acute myocardial infarction.
    Marshall CJ; Nallaratnam M; Mocatta T; Smyth D; Richards M; Elliott JM; Blake J; Winterbourn CC; Kettle AJ; McClean DR
    Am J Cardiol; 2010 Aug; 106(3):316-22. PubMed ID: 20643239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease.
    Yang SW; Zhou YJ; Tian XF; Pan GZ; Liu YY; Zhang J; Guo ZF; Chen SY; Gao ST; Du J; Jia DA; Fang Z; Hu B; Han HY; Gao F; Hu DY; Xu YY;
    Mayo Clin Proc; 2013 Sep; 88(9):930-41. PubMed ID: 24001485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The usefulness of myeloperoxidase in prediction of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Stankovic S; Asanin M; Majkic-Singh N; Ignjatovic S; Mihailovic M; Nikolajevic I; Mrdovic I; Matic D; Savic L; Marinkovic J; Ostojic M; Vasiljevic Z
    Clin Lab; 2012; 58(1-2):125-31. PubMed ID: 22372355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: implications for cardiac outcome.
    Dullaart RP; Tietge UJ; Kwakernaak AJ; Dikkeschei BD; Perton F; Tio RA
    Atherosclerosis; 2014 May; 234(1):185-92. PubMed ID: 24661908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple inflammatory prognostic factors in acute coronary syndromes: a prospective inception cohort study.
    Hatmi ZN; Saeid AK; Broumand MA; Khoshkar SN; Danesh ZF
    Acta Med Iran; 2010; 48(1):51-7. PubMed ID: 21137670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic performance of myeloperoxidase plasma levels compared with sensitive troponins in patients admitted with acute onset chest pain.
    Rudolph V; Keller T; Schulz A; Ojeda F; Rudolph TK; Tzikas S; Bickel C; Meinertz T; Münzel T; Blankenberg S; Baldus S
    Circ Cardiovasc Genet; 2012 Oct; 5(5):561-8. PubMed ID: 22923422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction.
    Goldmann BU; Rudolph V; Rudolph TK; Holle AK; Hillebrandt M; Meinertz T; Baldus S
    Free Radic Biol Med; 2009 Jul; 47(1):79-83. PubMed ID: 19362143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations.
    Apple FS; Smith SW; Pearce LA; Schulz KM; Ler R; Murakami MM
    Clin Chem; 2011 Apr; 57(4):603-8. PubMed ID: 21262952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of serum neutrophil markers and acute coronary syndrome.
    Alfakry H; Sinisalo J; Paju S; Nieminen MS; Valtonen V; Tervahartiala T; Pussinen PJ; Sorsa T
    Scand J Immunol; 2012 Aug; 76(2):181-7. PubMed ID: 22537345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.
    Januzzi JL; Newby LK; Murphy SA; Pieper K; Antman EM; Morrow DA; Sabatine MS; Ohman EM; Cannon CP; Braunwald E
    Am Heart J; 2006 Feb; 151(2):360-6. PubMed ID: 16442899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloperoxidase activity and acute coronary syndrome survival: long-term evaluation in the ERICO study.
    Quidim AV; Bruno TC; Lacerda Leocádio PC; Dos Reis Menta PL; Alvarez-Leite JI; Santos IS; Lotufo PA; Benseñor IM; Goulart AC
    Biomark Med; 2018 Nov; 12(11):1219-1229. PubMed ID: 30456985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of elevated levels of plasma myeloperoxidase to impaired myocardial microcirculation after reperfusion in patients with acute myocardial infarction.
    Yunoki K; Naruko T; Komatsu R; Shirai N; Nakagawa M; Sugioka K; Ikura Y; Kusano KF; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Am J Cardiol; 2010 Apr; 105(7):922-9. PubMed ID: 20346307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma myeloperoxidase concentration predicts the presence and severity of coronary disease in patients with chest pain and negative troponin-T.
    Rebeiz AG; Tamim HM; Sleiman RM; Abchee AG; Ibrahim Z; Khoury MY; Youhanna S; Skouri HN; Alam SE
    Coron Artery Dis; 2011 Dec; 22(8):553-8. PubMed ID: 21934609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of MPO in patients admitted for suspected acute coronary syndrome--a study of adult in Mostar, Bosnia and Herzegovina.
    Vasilj M; Starcević B; Volarić M; Jelavić B; Leventić M; Cuk D; Corić S
    Coll Antropol; 2014 Mar; 38(1):213-7. PubMed ID: 24851620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.